What does TRANSBIG stand for?
TRANSBIG is an abbreviation for “Translating molecular knowledge into early breast cancer management: building on the BIG network for improved treatment tailoring.” TRANSBIG refers to a new research network involving 40 partners in 22 different countries in Europe. TRANSBIG was created to accelerate the incorporation of new technologies into the breast cancer clinical practice. Translational research is a new type of research that provides the link between the discoveries in the laboratory (basic science research) and their application for the benefit of patients (clinical research). It functions as a bridge between these two worlds and is based on two principles often referred to as “bench to bedside” and “bedside to bench”.
